IL6 and COVID-19: Furthermore, IL-6 concentrations correlate with other markers of systemic inflammation including CRP and soluble tumor necrosis factor receptor 1 (TNFR1) in patients with acute respiratory distress syndrome (ARDS) from COVID-19 (5).